Zoetis reported financial results for the first quarter that were slightly better than Wall Street expected, as worries about ...

Zoetis (ZTS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Zoetis, a leading animal health company, shows impressive revenue growth despite drug safety concerns. Click here to read my ...

Phibro Animal Health Corporation's deal with Zoetis looks promising, but lackluster performance over many years leaves room ...

Zoetis reported a 10% Y/Y revenue increase to $2.190 billion, driven by strong performance in the U.S. segment, with sales up ...

Zoetis (ZTS) reports better-than-expected first-quarter results, wherein both earnings and revenues beat estimates. Shares ...

Zoetis (NYSE: ZTS) Q1 2024 Earnings Call May 02, 2024, 8:30 a.m. ET ...

Zoetis reported healthy beats on the top and bottom lines. Growth took place in both its U.S. and international segments, with the companion animal products business leading the way. The animal ...

Animal healthcare company Zoetis surpassed analysts' expectations for first-quarter profit on Thursday, helped by strong demand for its medicines and vaccines for pets.

For its first quarter, Zoetis earned revenue of $2.2 billion, which was a 10% improvement over the same period of 2023. Non-GAAP (adjusted) net income also headed north, by 4% year over year to $ ...

PARSIPPANY, N.J. — PARSIPPANY, N.J. — Zoetis Inc. (ZTS) on Thursday reported first-quarter earnings of $599 million. On a per-share basis, the Parsippany, New Jersey-based company said it had profit ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...